Hytrin (Terazosin)

Brand Options

arrow pointer

Brand Name : Hytrin

Marketing Authorization Holder : Advanz Pharma

Prescription Required

 
 

Generic Option

arrow pointer2

Generic Name : Terazosin

Manufactured By : Authorized UK Generic

Prescription Required

 
 

Product Details

Hytrin

Information about Hytrin (Terazosin)

Hytrin is an oral medication containing terazosin, which belongs to a class of drugs known as alpha-1 adrenergic antagonists. It works by relaxing the muscles in the blood vessels and the prostate, improving blood flow and easing urinary symptoms.

Product Highlights

  • Treatment of hypertension (high blood pressure)
  • Management of benign prostatic hyperplasia (BPH) to relieve urinary symptoms
  • Blocks alpha-1 adrenergic receptors, leading to vasodilation and relaxation of the prostate and bladder neck muscles

Key Ingredient

  • Terazosin

Key Benefits

  • Effectively lowers blood pressure, reducing the risk of cardiovascular complications.
  • Eases urinary symptoms associated with an enlarged prostate, such as difficulty urinating and frequent urination.
  • Convenient dosing schedule that enhances patient compliance.

Direction of Use

  • Taken orally, usually once daily at bedtime to minimize the risk of dizziness.
  • Regular blood pressure checks are recommended to ensure effectiveness and safety.
  • Adhere to the dosage and schedule recommended by your healthcare provider.

Safety Concerns

  • Risk of dizziness or fainting upon standing; caution is advised when rising quickly.
  • Some patients might feel fatigued or weak.
  • Common side effect due to vasodilation in the nasal passages.
  • Rare but serious side effect involving prolonged and painful erections; seek immediate medical attention if this occurs.

Avoid Hytrin (Terazosin) If

  • You have a known allergy to terazosin or other similar medications.
  • You have a history of severe hypotension or are experiencing low blood pressure.
  • You are taking other medications that may interact adversely, such as PDE-5 inhibitors or other antihypertensives.
  • You are pregnant or breastfeeding without first discussing it with your healthcare provider.


Image Image Image Image